BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19417756)

  • 1. In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia.
    Klohs J; Baeva N; Steinbrink J; Bourayou R; Boettcher C; Royl G; Megow D; Dirnagl U; Priller J; Wunder A
    J Cereb Blood Flow Metab; 2009 Jul; 29(7):1284-92. PubMed ID: 19417756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice.
    Klohs J; Steinbrink J; Bourayou R; Mueller S; Cordell R; Licha K; Schirner M; Dirnagl U; Lindauer U; Wunder A
    J Neurosci Methods; 2009 May; 180(1):126-32. PubMed ID: 19427539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
    Deguchi JO; Aikawa M; Tung CH; Aikawa E; Kim DE; Ntziachristos V; Weissleder R; Libby P
    Circulation; 2006 Jul; 114(1):55-62. PubMed ID: 16801460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice.
    Koistinaho M; Malm TM; Kettunen MI; Goldsteins G; Starckx S; Kauppinen RA; Opdenakker G; Koistinaho J
    J Cereb Blood Flow Metab; 2005 Apr; 25(4):460-7. PubMed ID: 15674236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene.
    Myochin T; Hanaoka K; Komatsu T; Terai T; Nagano T
    J Am Chem Soc; 2012 Aug; 134(33):13730-7. PubMed ID: 22830429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
    Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH
    J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat.
    Amantea D; Russo R; Gliozzi M; Fratto V; Berliocchi L; Bagetta G; Bernardi G; Corasaniti MT
    Int Rev Neurobiol; 2007; 82():149-69. PubMed ID: 17678960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certain forms of matrix metalloproteinase-9 accumulate in the extracellular space after microdialysis probe implantation and middle cerebral artery occlusion/reperfusion.
    Planas AM; Justicia C; Solé S; Friguls B; Cervera A; Adell A; Chamorro A
    J Cereb Blood Flow Metab; 2002 Aug; 22(8):918-25. PubMed ID: 12172377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice.
    Copin JC; Goodyear MC; Gidday JM; Shah AR; Gascon E; Dayer A; Morel DM; Gasche Y
    Eur J Neurosci; 2005 Oct; 22(7):1597-608. PubMed ID: 16197500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence that the increase in matrix metalloproteinase activity occurs early after cerebral ischemia.
    Martín A; Garofalakis A; Tavitian B
    Mol Imaging; 2012 Feb; 11(1):22-6. PubMed ID: 22418024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.
    Lee KJ; Jang YH; Lee H; Yoo HS; Lee SR
    Eur J Neurosci; 2008 Jan; 27(2):334-42. PubMed ID: 18215232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
    Morancho A; Rosell A; García-Bonilla L; Montaner J
    Ann N Y Acad Sci; 2010 Oct; 1207():123-33. PubMed ID: 20955435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "One-step" detection of matrix metalloproteinase activity using a fluorogenic peptide probe-immobilized diagnostic kit.
    Ryu JH; Lee A; Lee S; Ahn CH; Park JW; Leary JF; Park S; Kim K; Kwon IC; Youn IC; Choi K
    Bioconjug Chem; 2010 Jul; 21(7):1378-84. PubMed ID: 20575580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage.
    Shichi K; Fujita-Hamabe W; Harada S; Mizoguchi H; Yamada K; Nabeshima T; Tokuyama S
    J Pharmacol Exp Ther; 2011 Aug; 338(2):701-10. PubMed ID: 21602423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia.
    Lee SR; Kim HY; Hong JS; Baek WK; Park JW
    Biochem Biophys Res Commun; 2009 Feb; 380(1):17-21. PubMed ID: 19135426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model.
    Royl G; Balkaya M; Lehmann S; Lehnardt S; Stohlmann K; Lindauer U; Endres M; Dirnagl U; Meisel A
    Brain Res; 2009 Apr; 1265():148-57. PubMed ID: 19368809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice.
    Liu N; Shang J; Tian F; Nishi H; Abe K
    Brain Res; 2011 Jun; 1397():66-75. PubMed ID: 21571257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe.
    Ryu JH; Lee A; Chu JU; Koo H; Ko CY; Kim HS; Yoon SY; Kim BS; Choi K; Kwon IC; Kim K; Youn I
    Arthritis Rheum; 2011 Dec; 63(12):3824-32. PubMed ID: 22127700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats.
    Tanaka H; Takai S; Jin D; Furubayashi K; Inoue N; Kajimoto Y; Miyatake S; Kuroiwa T; Miyazaki M
    Hypertens Res; 2007 May; 30(5):469-75. PubMed ID: 17587759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia.
    Cuadrado E; Rosell A; Borrell-Pagès M; García-Bonilla L; Hernández-Guillamon M; Ortega-Aznar A; Montaner J
    J Cereb Blood Flow Metab; 2009 Feb; 29(2):398-410. PubMed ID: 18985055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.